KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Intangibles: 2009-2011

Historic Intangibles for Alnylam Pharmaceuticals (ALNY) over the last 3 years, with Dec 2011 value amounting to $275,000.

  • Alnylam Pharmaceuticals' Intangibles fell 54.40% to $145,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $145,000, marking a year-over-year decrease of 54.40%. This contributed to the annual value of $275,000 for FY2011, which is 38.62% down from last year.
  • According to the latest figures from FY2011, Alnylam Pharmaceuticals' Intangibles is $275,000, which was down 38.62% from $448,000 recorded in FY2010.
  • In the past 5 years, Alnylam Pharmaceuticals' Intangibles registered a high of $867,659 during FY2009, and its lowest value of $275,000 during FY2011.
  • Over the past 3 years, Alnylam Pharmaceuticals' median Intangibles value was $448,000 (recorded in 2010), while the average stood at $530,220.
  • Data for Alnylam Pharmaceuticals' Intangibles shows a maximum YoY tumbled of 48.37% (in 2010) over the last 5 years.
  • Over the past 3 years, Alnylam Pharmaceuticals' Intangibles (Yearly) stood at $867,659 in 2009, then slumped by 48.37% to $448,000 in 2010, then slumped by 38.62% to $275,000 in 2011.